Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment

Annals of Hematology

Volumn 84, Issue 7, 2005, Pages 456-461

  Lysak, D ^a   Koza, V ^a   Steinerova, K ^a   Jindra, P ^a   Vozobulova, V ^a   Schutzova, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

CLL; Fludarabine; Mobilization; PBSC

Indexed keywords

CARMUSTINE; CD34 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FLUDARABINE; HEMOGLOBIN; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGE; AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER PATIENT; CANCER REGRESSION; CANCER STAGING; CELL COUNT; CELL ISOLATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CYCLOPHOSPHAMIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; VIDARABINE;

EID: 20944432005     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1008-6     Document Type: Article

References (23)

1. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C (1995) Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547-2555 1:STN:280:BymD3cjlsl0%3D
2. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR (1996) National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 87:4990-4997 1:CAS:528:DyaK28XjsFGisb8%3D
3. Demirer T, Buckner CD, Bensinger WI (1996) Optimization of peripheral blood stem cell mobilization. Stem Cells 14:106-116
4. Demirer T, Buckner CD, Gooley T, Appelbaum FR, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger WI (1996) Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 17:937-941 1:STN:280:BymH3c%2Fnt1U%3D
5. Dreger P, von Neuhoff N, Kuse R, Sonnen R, Glass B, Uharek L, Schoch R, Loffler H, Schmitz N (1998) Early stem cell transplantation for chronic lymphocytic leukemia: A chance for cure? Br J Cancer 77:2291-2297
6. Dreger P, Michallet M, Schmitz N (2000) Stem-cell transplantation for chronic lymphocytic leukemia: The 1999 perspective. Ann Oncol 11:S49-S53
7. Dreger P, Montserrat E (2002) Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia. Leukemia 16:985-992
8. Flinn IW, Byrd JC, Morrison C, Jamison J, Diehl LF, Murphy T, Piantadosi S, Seifter E, Ambinder RF, Vogelsang G, Grever MR (2000) Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies. Blood 96:71-75
9. Fruehauf S, Seggewiss R (2003) It's moving day: Factors affecting peripheral blood stem mobilization and strategies for improvement. Br J Haematol 122:360-375
10. Iẗl̈ M, Pelliniemi T-T, Rajam̈ki A, Remes K (1997) Autologous blood cell transplantation in B-CLL: Response to chemotherapy prior to mobilization predicts the stem cell yield. Bone Marrow Transplant 19:647-651
11. Johnson S, Smith AG, Loffler H, Osby E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W (1996) Multicentre prospective randomized trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukemia. The French Cooperative Group on CLL. Lancet 347:1432-1438
12. Ketterer N, Salles G, Moullet I, Dumontet C, ElJaafari-Corbin A, Tremisi P, Thieblemont C, Durand B, Neidhardt-Berard EM, Samaha H, Rigal D, Coiffier B (1998) Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 103:235-242
13. Laszlo D, Galieni P, Raspadori D, Scalia G, Bigazzi C, Bocchia M, Bucalossi A, Marotta G, Tozzi M, Lauria F (2000) Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patients. Leuk Lymphoma 37:157-161
14. Lie AKW, Hui CH, Rawling T, Dyson PG, Thorp D, Benic J, Rawling CM, Toogood I, Horvath N, Simmons PJ, To LB (1998) Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who failed initial mobilization with chemotherapy and G-CSF. Bone Marrow Transplant 22:853-857
15. McQuaker I, Haznes A, Stainer C, Byrne J, Russell N (1999) Mobilization of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease. Bone Marrow Transplant 24:715-722
16. Micallef I, Apostolidis J, Rohatiner A, Wiggins C, Crawley CR, Foran JM, Leonhardt M, Bradburn M, Okukenu E, Salam A, Matthews J, Cavenagh JD, Gupta RK, Lister TA (2000) Factors which predict unsuccessful mobilization of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma. Hematol J 1:367-373
17. Michallet M, Thiébaut A, Dreger P, Remes K, Milpied N, Santini G, Hamon M, Björkstrand B, Kimby E, Belhabri A, Tanguy ML, Apperley JF (2000) Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): A report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP). Br J Haematol 108:595-601
18. Montillo M, Tedeschi A, Rossi V, Cairoli R, Pungolino E, Intropido L, Cafro AM, D'Avanzo G, Farioli R, Brando B, Scarpati B, Veronese S, Morra E (2004) Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H. Leukemia 18:57-62
19. Provan D, Bartlett-Pandite L, Zwicky C, Neuberg D, Maddocks A, Corradini P, Soiffer R, Ritz J, Nadler LM, Gribben JG (1996) Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 88:2228-2235
20. Reiser M, Josting A, Draube A, Mapara MY, Scheid C, Chemnitz J, Tesch H, Wolf J, Diehl V, Söhngen D, Engert A (1999) Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization. Bone Marrow Transplant 23:1223-1228
21. Scimè R, Indovina A, Santoro A, Musso M, Olivieri A, Tringali S, Crescimanno A, Montanari M, Felice R, Catania P, Mariani G, Leoni P, Majolino I (1998) PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. Bone Marrow Transplant 22:1159-1165
22. Tarella C, Zallio F, Caracciolo D, Cherasco C, Bondesan P, Gavarotti P, Corradini P, Tassi V, Pileri A (1999) Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients. Stem Cells 17:55-61
23. Tournilhac O, Cazin B, Leprètre S, Divinè M, Maloum K, Delmer A, Grosbois B, Feugier P, Maloisel F, Villard F, Villemagne B, Bastit D, Belhadj K, Azar N, Michallet M, Manh's G, Travade P 2004 Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. Blood 103 363-365